Characterization of immunostimulatory components of orf virus (parapoxvirus ovis)

Journal of General Virology

Volumn 92, Issue 7, 2011, Pages 1571-1584

  Friebe, Astrid ^a,e   Friederichs, Sonja ^b   Scholz, Kai ^b,f   Janssen, Uwe ^c   Scholz, Corinna ^c   Schlapp, Tobias ^b,f   Mercer, Andrew ^d   Siegling, Angela ^b,g   Volk, Hans Dieter ^a   Weber, Olaf ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BAYER PHARMA AG   (Germany)

^c MILTENYI BIOTEC GMBH   (Germany)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f Essex Animal Health Burgwedel   (Germany)

^g Intellectual Property Management   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CD14 ANTIGEN; DNA FRAGMENT; GAMMA INTERFERON; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VALACICLOVIR; VVOV 215 PROTEIN; VVOV 243 PROTEIN; VVOV 245 PROTEIN; VVOV 285 PROTEIN; VVOV 330 PROTEIN; VVOV 96 PROTEIN; VVOV 97 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INTRACELLULAR SIGNALING; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OPEN READING FRAME; PARAPOXVIRUS OVIS; POXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PSEUDORABIES HERPETOVIRUS; SIGNAL TRANSDUCTION; TH1 CELL; VACCINIA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS IDENTIFICATION; VIRUS IMMUNITY; VIRUS MORPHOLOGY;

ANIMALS; ANTIGEN-PRESENTING CELLS; CATTLE; CELL LINE; ECTHYMA, CONTAGIOUS; FEMALE; HUMANS; MICE; ORF VIRUS; VIRAL PROTEINS;

ANIMALIA; ORF VIRUS; OVIS; PARAPOXVIRUS;

EID: 79959304914     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.028894-0     Document Type: Article

References (35)

1. Alpdogan, O. & van den Brink, M. R. (2005). IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol 26, 56-64.
2. Annes, J. P., Munger, J. S. & Rifkin, D. B. (2003). Making sense of latent TGFb activation. J Cell Sci 116, 217-224.
3. Ansel, K. M., Harris, R. B. & Cyster, J. G. (2002). CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16, 67-76.
4. Ben-Baruch, A., Grimm, M., Bengali, K., Evans, G. A., Chertov, O., Wang, J. M., Howard, O. M., Mukaida, N., Matsushima, K. & Oppenheim, J. J. (1997). The differential ability of IL-8 and neutrophil-activating peptide-2 to induce attenuation of chemotaxis is mediated by their divergent capabilities to phosphorylate CXCR2 (IL-8 receptor B). J Immunol 158, 5927-5933.
5. Culley, F. J., Pennycook, A. M., Tregoning, J. S., Dodd, J. S., Walzl, G., Wells, T. N., Hussell, T. & Openshaw, P. J. (2006). Role of CCL5 (RANTES) in viral lung disease. J Virol 80, 8151-8157.
6. Dillon, S. R., Gross, J. A., Ansell, S. M. & Novak, A. J. (2006). An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5, 235-246.
7. Elsbach, P. & Weiss, J. (1993). The bactericidal/permeabilityincreasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 187, 417-429.
8. Fothergill, T. & McMillan, N. A. (2006). Papillomavirus virus-like particles activate the PI3-kinase pathway via a-6 b-4 integrin upon binding. Virology 352, 319-328.
9. Friebe, A., Siegling, A., Friederichs, S., Volk, H. D. & Weber, O. (2004). Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells. J Virol 78, 9400- 9411.
10. Fukao, T. & Koyasu, S. (2003). PI3K and negative regulation of TLR signaling. Trends Immunol 24, 358-363.
11. Glass, W. G., Rosenberg, H. F. & Murphy, P. M. (2003). Chemokine regulation of inflammation during acute viral infection. Curr Opin Allergy Clin Immunol 3, 467-473.
12. Go ́ mez, C. E. & Esteban M. (2001). Recombinant proteins produced by vaccinia virus vectors can be incorporated within the virion (IMV form) into different compartments. Arch Virol 146, 875-892.
13. Groseil, C., Guerin, P. & Adamowicz, P. (1995). Evaluation by polymerase chain reaction on the effect of b-propiolactone and binary ethyleneimine on DNA. Biologicals 23, 213-220.
14. Haig, D. M., Thomson, J., McInnes, C., McCaughan, C., Imlach, W., Mercer, A. & Fleming, S. (2002). Orf virus immuno-modulation and the host immune response. Vet Immunol Immunopathol 87, 395-399.
15. Harper, J. M. M., Parsonage, M. T., Pelham, H. R. B. & Darby, G. (1978). Heat inactivation of vaccinia virus particle-associated functions: properties of heated particles in vivo and in vitro. J Virol 26, 646-659.
16. Johnston, J. B., Barrett, J. W., Nazarian, S. H., Goodwin,M., Ricciuto, D., Wang, G. & McFadden, G. (2005). A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 23, 587-598.
17. Krieg, A. M. (2002). CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20, 709-760.
18. Kumar, D., Hosse, J., von Toerne, C., Noessner, E. & Nelson, P. J. (2009). JNK MAPK pathway regulates constitutive transcription of CCL5 by human NK cells through SP1. J Immunol 182, 1011-1020.
19. Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S. & Dixit, V. M. (2004). Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218.
20. Marteau, F., Gonzalez, N. S., Communi, D., Goldman, M., Boeynaems, J. M. & Communi, D. (2005). Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 106, 3860-3866.
21. Masli, S., Turpie, B. & Streilein, J. W. (2006). Thrombospondin orchestrates the tolerance-promoting properties of TGFb-treated antigen-presenting cells. Int Immunol 18, 689-699.
22. Mastroianni, C. M., d'Ettorre, G., Forcina, G. & Vullo, V. (2004). Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy? Trends Immunol 25, 121-125.
23. Mercer, A. A., Yirrell, D. L., Whelan, E. M., Nettleton, P. F., Pow, I., Gilray, J. A., Reid, H. W. & Robinson, A. J. (1997). A novel strategy for determining protective antigens of the parapoxvirus, orf virus. Virology 229, 193-200.
24. Mercer, A. A., Ueda, N., Friederichs, S. M., Hofmann, K., Fraser, K. M., Bateman, T. & Fleming, S. B. (2006). Comparative analysis of genome sequences of three isolates of Orf virus reveals unexpected sequence variation. Virus Res 116, 146-158.
25. Ng, L. G., Mackay, C. R. & Mackay, F. (2005). The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 42, 763-772.
26. Penna, G., Vulcano, M., Sozzani, S. & Adorini, L. (2002). Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 63, 1164-1171.
27. Perez, O. D., Kinoshita, S., Hitoshi, Y., Payan, D. G., Kitamura, T., Nolan, G. P. & Lorens, J. B. (2002). Activation of the PKB/AKT pathway by ICAM-2. Immunity 16, 51-65.
28. Resch, W., Hixson, K. K., Moore, R. J., Lipton, M. S. & Moss, B. (2007). Protein composition of the vaccinia virus mature virion. Virology 358, 233-247.
29. Rodriguez, J. F., Paez, E. & Esteban, M. (1987). A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J Virol 61, 395-404.
30. Schramm, C., Huber, S., Protschka, M., Czochra, P., Burg, J., Schmitt, E., Lohse, A. W., Galle, P. R. & Blessing, M. (2004). TGFb regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo. Int Immunol 16, 1241-1249.
31. Trifilo, M. J. & Lane, T. E. (2004). The CC chemokine ligand 3 regulates CD11c+CD11b+CD8a2 dendritic cell maturation and activation following viral infection of the central nervous system: implications for a role in T cell activation. Virology 327, 8-15.
32. Wang, S., Miura, M., Jung, Y. K., Zhu, H., Li, E. & Yuan, J. (1998). Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501-509.
33. Weber, O., Siegling, A., Friebe, A., Limmer, A., Schlapp, T., Knolle, P., Mercer, A., Schaller, H. & Volk, H. D. (2003). Inactivated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus. J Gen Virol 84, 1843-1852.
34. Wittek, R., Kuenzle, C. C. & Wyler, R. (1979). High C+G content in parapoxvirus DNA. J Gen Virol 43, 231-234.
35. Zhai, Y., Qiao, B., Shen, X. D., Gao, F., Busuttil, R. W., Cheng, G., Platt, J. L., Volk, H. D. & Kupiec-Weglinski, J. W. (2008). Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischemia and reperfusion injury. Transplantation 85, 1016-1022.